Knight Campus innovator Ong elected to inventors group miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Photo Credit: Getty Images
It was announced on Feb. 19 that the National Composites Centre (NCC, Bristol, U.K.) will be playing an important role in a bilateral international program between the U.K. and Australia to accelerate the integration of advanced materials into military platforms.
Nine partner teams across both nations have received Phase 2 funding worth a total of £1.48 million ($2.82 million USD) from the U.K. and Australian governments to develop innovative proposals covering integration of composites, adhesives for structural joining, joining high-temperature structures and improving armor systems.
U.K. consortia include:
TWI Ltd.
Zentraxa Ltd. and QinetiQ Australia
Australian teams involve:
MIL-OSI United Kingdom: UK and Australia collaborate to accelerate advanced materials integration foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.
UK and Australia collaborate to accelerate advanced materials integration
Funding for innovative proposals covering integration of composites, adhesives for structural joining, joining high temperature structures and improving armour systems
From:
17 February 2021 The UK and Australian governments are funding innovative proposals to integrate advanced materials into military platforms such as armoured vehicles
Defence research and development ties between the UK and Australia are already strong, but have been strengthened further under a bilateral international program to accelerate the integration of advanced materials into military platforms.
Nine teams of partners across both nations have received Phase 2 funding worth a total of £1.48 million (A$2.82 million) from the UK and Australian governments to develop innovative proposals covering integration of composites, adhesives for structural joining, joining high temperature structures and improving armour systems
Groundbreaking therapy may provide a new treatment modality for biofilm infections in foot ulcers
A new £1.7m project to explore using plasma jets and antimicrobial dressings to treat debilitating - and potentially deadly - wound infections launches today.
The groundbreaking Plasma-activated Antimicrobial Hydrogel Therapy (PAHT) would provide a new treatment modality for biofilm infections in diabetic foot ulcers (DFUs), a type of wound which make up around 10 per cent of the 2.2m wounds reported annually in the UK.
More than a third of the +4.5m diabetics in the UK have a lifetime risk of foot ulcers, of which 50 per cent become infected. Around 10 per cent of these patients then require lower limb amputation due to tissue and bone infection. The prognosis for these patients is bleak; 44 per cent usually die within five years.